Your browser doesn't support javascript.
loading
Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort.
Adviento, Brigid A; Regan, Elizabeth A; Make, Barry J; Han, MeiLan K; Foreman, Marilyn G; Iyer, Anand S; Bhatt, Surya P; Kim, Victor; Bon, Jessica; Soler, Xavier; Kinney, Gregory L; Hanania, Nicola A; Lowe, Katherine E; Holm, Kristen E; Yohannes, Abebaw M; Shinozaki, Gen; Hoth, Karin F; Fiedorowicz, Jess G.
Afiliação
  • Adviento BA; Department of Psychiatry, University of Iowa, Iowa City, IA; Department of Internal Medicine, University of Iowa, Iowa City, IA.
  • Regan EA; Division of Rheumatology, Department of Medicine, National Jewish Health, Denver, CO.
  • Make BJ; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
  • Han MK; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
  • Foreman MG; Pulmonary and Critical Care Medicine Division, Morehouse School of Medicine, Atlanta, GA.
  • Iyer AS; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL.
  • Bhatt SP; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL.
  • Kim V; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
  • Bon J; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA; VA Pittsburgh Healthcare System, Pittsburgh, PA.
  • Soler X; Department of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, San Diego, CA.
  • Kinney GL; Department of Epidemiology, Colorado School of Public Health, University of Colorado, Aurora, CO.
  • Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX.
  • Lowe KE; Case Western Reserve University School of Medicine, Cleveland, OH.
  • Holm KE; Division of Neurology and Behavioral Health, National Jewish Health, Denver, CO; Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado, Aurora, CO.
  • Yohannes AM; Department of Physical Therapy, Azusa Pacific University, Azusa, CA.
  • Shinozaki G; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA.
  • Hoth KF; Department of Psychiatry, University of Iowa, Iowa City, IA; Iowa Neuroscience Institute, University of Iowa, Iowa City, IA. Electronic address: karin-hoth@uiowa.edu.
  • Fiedorowicz JG; Ottawa Hospital, Ottawa Hospital Research Institute, and University of Ottawa, Ottawa, Ontario, Canada.
Chest ; 163(2): 292-302, 2023 02.
Article em En | MEDLINE | ID: mdl-36167120
ABSTRACT

BACKGROUND:

Studies have shown that COPD and smoking are associated with increased suicide risk. To date, there are no prospective studies examining suicide risk among individuals with smoking exposure along a spectrum of pulmonary diseases ranging from normal spirometry to severe COPD. RESEARCH QUESTION Which clinical variables predict death by suicide or overdose of indeterminate intent in a large cohort of individuals with smoking exposure within the Genetic Epidemiology of COPD (COPDGene) study? STUDY DESIGN AND

METHODS:

We studied data from 9,930 participants involved in COPDGene, a multisite, prospective cohort study of individuals with smoking exposure. Primary cause of adjudicated deaths was identified by using death certificates, family reports, and medical records. Time to death by suicide/overdose was examined as the primary outcome in Cox regression models including age, sex, race, BMI, pack-years, current smoking status, airflow limitation (FEV1 % predicted), dyspnea (modified Medical Research Council scale score ≥ 2), 6-min walk distance, supplemental oxygen use, and severe exacerbations in the prior year with time-varying covariates and other causes of death as a competing risk.

RESULTS:

The cohort was 47% female and 33% Black (67% White); they had a mean ± SD age of 59.6 ± 9.0 years and a mean FEV1 % predicted of 76.1 ± 25.5. Sixty-three individuals died by suicide/overdose. Factors associated with risk of suicide/overdose were current smoking (hazard ratio [HR], 6.44; 95% CI, 2.64-15.67), use of sedative/hypnotics (HR, 2.33; 95% CI, 1.24-4.38), and dyspnea (HR, 2.23; 95% CI, 1.34-3.70). Lower risk was associated with older age (per-decade HR, 0.45; 95% CI, 0.31-0.67), higher BMI (HR, 0.95; 95% CI, 0.91-0.99), and African-American race (HR, 0.41; 95% CI, 0.23-0.74). Severity of airflow limitation (FEV % predicted) was not associated with suicide risk.

INTERPRETATION:

In this well-characterized cohort of individuals with smoking exposure with and without COPD, risk factors for suicide/overdose were identified that emphasize the subjective experience of illness over objective assessments of lung function.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Overdose de Drogas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Overdose de Drogas Idioma: En Ano de publicação: 2023 Tipo de documento: Article